Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -19.131\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) COc1cccc(/C=N/NC(=O)CSCC(=O)Nc2ccccc2)c1O
b) CCc1cc(=O)[nH]c(SCC(=O)Nc2cc(C)on2)n1
c) c1ccc(CN2CCN(Cc3c[nH]c4ccccc34)CC2)cc1
d) CCCCn1c(SCC(=O)N2CCC(C)CC2)nc2ccsc2c1=O
Answer: d. CCCCn1c(SCC(=O)N2CCC(C)CC2)nc2ccsc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCn1c(SCC(=O)N2CCC(C)CC2)nc2ccsc2c1=O
CCCCn1c(SCC(=O)N2CCC(C)CC2)nc2ccsc2c1=O
3-butyl-2-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]sulfanylthieno[3,2-d]pyrimidin-4-one